An international team of investigators from centers in the United States and the United Kingdom, including Weill Cornell Medical College, have been awarded a grant for $10 million over a three-year period to study the molecular underpinnings of metastatic prostate cancer while creating a comprehensive testing system to optimize personalized treatments. The award was announced Sunday, April 1, during a press conference at the American Association for Cancer Research (AACR) 2012 Annual Meeting, held in Chicago from March 31 through April 4, 2012.
